A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study.
Saved in:
| Title: | A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study. |
|---|---|
| Authors: | Xicheng, Wang1 (AUTHOR), Yanhong, Deng2 (AUTHOR), Yanqiao, Zhang3 (AUTHOR), Tianshu, Liu4 (AUTHOR), Xianglin, Yuan5 (AUTHOR), Jianwei, Yang6 (AUTHOR), Tao, Zhang5 (AUTHOR), Aimin, Zang7 (AUTHOR), Yu, Liu8 (AUTHOR), Li, Huang9 (AUTHOR), Feng, Ye10 (AUTHOR), Hong, Zong11 (AUTHOR), Yi, Ba12 (AUTHOR), Isabelle, Klauck13 (AUTHOR), Jean‐Claude, Vedovato13 (AUTHOR), Mélanie, Groc13 (AUTHOR), Angela, Guo14 (AUTHOR), Jian, Li1 (AUTHOR) oncogene@163.com, Lin, Shen1 (AUTHOR) |
| Source: | Cancer Medicine. Mar2026, Vol. 15 Issue 3, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
